In summary, this study highlights the potentiality of the paired pre‐ and post‐operation serum proteome signature for the detection of putative biomarkers for gastric carcinoma and reveals that SOX3 may serve as a candidate molecular marker for prognosis and outcomes of gastric cancer patients. The gene discussed is SOX3; the disease is gastric carcinoma.